clinical site Articles
-
A Survey of Environmental Safety Issues at 20 Medical Clinics
In the study described in this article, the authors performed safety walk-throughs or inspections for 20 clinics located both inside a major medical center clinic (onsite) and away from the main clinic site (offsite). A checklist was used to evaluate compliance with institutional, local, state, and federal guidelines and regulations. The results obtained at onsite clinics were compared with the ...
-
The QUEST Post-Amputation Pain Study - Case Study
The QUEST study (High-FreQUEncy Nerve Block for PoST-Amputation Pain), is a randomized controlled study of 180 patients at 25 clinical study sites in the U.S. Recruitment for the study was completed in late 2021. Results are blinded until after participants have finished a twelve-month follow-up. ...
-
Top Advances in Echocardiography Transforming Cardiac Imaging on World Heart Day
In honor of World Heart Day on September 29, we're diving into the world of cardiovascular diagnostics. Echocardiography, one of the most widely used screening and diagnostic modalities in healthcare, has seen a resurgence thanks to advances and groundbreaking innovations within the last few years. Join us as we explore the top trends shaping these diagnostic methods. 1. ...
-
Origin applies to China regulatory agency for clinical pathway classification
Origin, Inc., a Phase III clinical-stage biotechnology company, today announced that it had applied to NMPA (formerly CFDA) for classification of its plasma-generated nitric oxide device for the purposes of conducting clinical trials in Hong Kong and mainland China, and that NMPA had accepted its submission. A determination is expected within sixty business days. Origin is in preliminary ...
By Origin, Inc
-
User Satisfaction in Bionic Hands
If you’re reading this, it’s likely that you’re in the market for a new prosthetic hand, and perhaps a bionic hand at that. In the age of technology, user reviews are a crucial component of the shopping process. After all, why try out a product if thousands of others have already deemed it insufficient? The same goes for prosthetic hands. Amputees want to hear from other users ...
-
Comparison study of clinical outcomes between single-site robotic cholecystectomy and single incision laparoscopic cholecystectomy
Summary Background: Multiport laparoscopic cholecystectomy is the standard surgical procedure for symptomatic gallbladder diseases. The latest evolution is single incision laparoscopic cholecystectomy (SILC). Single-site robotic cholecystectomy (SSRC) overcomes several limitations of manual SILC. The aim of this study is to present our initial experiences in SSRC and to compare its clinical ...
-
Universal Diagnostics Initiates Observational Study in the US to Evaluate Cell Free DNA Blood Test for Adenomas and Colorectal Cancer
SEVILLE, Spain--(BUSINESS WIRE)--Universal Diagnostics (UDX), an in-vitro diagnostics company developing minimally-invasive, blood-based solutions for detecting cancer early, announced today that it has started a prospective, multi-center observational study in the US for its investigational advanced adenoma (precursor lesions) and colorectal cancer (CRC) detection blood test. UDX is performing ...
-
Regeneron’s High Profile Success? Demand for COVID-19 prophylactics – what role for Pichia expression technology to assist access
With Regeneron’s high profile, single-person, single-site, clinical trial proving successful (along with much supporting other clinical data!), will neutralising antibodies surf the second wave? Our COVID-related blogs focus on capacity and cost of making the treatments and understanding opportunities or bottlenecks in large scale provision and new innovations. In this context, we review ...
-
Set Up Your Clinical Trial For Success During The Holidays
The Holiday season often brings mixed feelings for many. While it can be a time of relaxation with friends and family for some, for others, preparing for this time means ensuring business continuity despite a typical slow down. This can be a source of undue stress if it is not suitably planned for. ...
-
Innovation Spotlight: Alucent Biomedical | Can we Make ‘Stents’ Obsolete?
As part of our ongoing Vascular Innovation Series in conjunction with The Way to My Heart, journalist Kym McNicholas interviewed Alucent Biomedical CEO, Dr. Myles Greenberg. Treatment for vascular blockages is getting a much-needed innovation makeover. Alucent’s first area of focus is one the most debilitating vascular diseases –peripheral artery disease, plaque build-up in mainly ...
-
What makes decentralisation the future of clinical trials?
With the emergence of COVID-19, Decentralisation of Clinical Trials became necessary to comply with social distancing requirements while carrying out clinical research. Over the past few years, the clinical trial landscape has shifted its focus to patient-centric practices to promote patient engagement. But now as the pandemic is long gone, it is time to reflect on how DCT studies are genuinely ...
By Clinion
-
What Clinical Trial Speed Factors Can Sponsors Actually Control?
When promising drug candidates are identified for further investigation in clinical trials, sponsor companies are usually optimistic about outcomes. But there are times, when after years of sunk effort and resources, clinical trials fail to bring a viable drug to market. Frequently, a drug fails for safety or efficacy reasons that are beyond a sponsor’s control. However, to some degree, ...
-
Essential Clinical Trial Systems for Small, Midsize, and Large Pharma
Revisiting the “why” behind decision making can be a helpful exercise in all aspects of business. This is no less true for clinical operations executives when it comes to the clinical trial systems they employ to facilitate their teams’ work. The technology that supports clinical trial systems has evolved steadily over the past several decades, yet the ultimate goal of ...
-
Nanostics Re-Opens ClarityDX Prostate Clinical Study with New US Recruitment Site
Summary Nanostics' clinical validation study for ClarityDX Prostate, a liquid biopsy test for the early diagnosis of clinically significant prostate cancer, re-opens recruitment after lifting of COVID-19 research restrictions A top-ranked research institute in the Northeast US will now partner with Nanostics' by recruiting patients for the clinical validation study This partnership will ...
-
BeadReady™ successfully storing cells for 3D biofabrication
Another fantastic publication highlighting one of the multiple applications Atelerix products have within the scientific research and development industry. Anastassia Kostenko , Che J. Connon, and Stephen Swioklo (2023), have successfully shown that Atelerix BeadReady™ is a simple, adaptable solution for room temperature cell storage in combination with biofabrication and how this can be ...
By Atelerix Ltd
-
Cleveland Clinic: First Case Completed in Feasibility Study of Non-Radiation-Based EVAR Navigation Platform
MOTION study will quantify new technology’s impact on radiation exposure In December, Cleveland Clinic vascular surgeons successfully completed the first surgical case in the MOTION clinical trial of a new non-radiation-based surgical navigation platform for endovascular aortic interventions. The trial is a feasibility study of the Intra-Operative Positioning System (IOPS™) from ...
-
Point of care pulmonary function testing: Important now, more than ever
As the relentless waves of the COVID-19 pandemic continue to wash over the world, much attention has been focused on the idea of hospital bed shortages. As cases strain hospital systems everywhere, the most-commonly reported metrics one hears have to do with beds; how many ICU beds left, how many emergency beds, how many beds overall. While it is of course critical to understand how much physical ...
-
Nanostics Announces Study Data Supporting ClarityDX Prostate as a Reflex Test to Predict Clinically Significant Prostate Cancer
Real-world data shows that at a 94% sensitivity level for prostate cancer ClarityDX Prostate® is 147% more specific than the PSA test for predicting clinically significant prostate cancer. Using ClarityDX Prostate® as a reflex test vs. PSA test alone could have resulted in 37% fewer unnecessary biopsies. The clinical study recruited men from two sites in Alberta, Canada, and one site ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you